Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 27753r.p.

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 27753r.p. in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(27753r.p.)		Trials
(27753r.p.)		Recent Studies (post-2010) (27753r.p.)
9,156187552800

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baudouy, N; Blanchard, JC; Brun, V; Goze, O; Laduron, PM; Levy, C; Zundel, JL1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 27753r.p.

ArticleYear
High affinity acceptor sites in guinea pig brain for [3H]52770 RP, a PAF antagonist.
    Fundamental & clinical pharmacology, 1989, Volume: 3, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Brain; Cations; Cerebral Cortex; Guinea Pigs; In Vitro Techniques; Male; Membranes; Peptides; Platelet Activating Factor; Proteins; Receptors, Drug; Stereoisomerism

1989